Dr. Joel Schlessinger and his son Daniel’s invention, FixMySkin Healing Balms, featured on YouBeauty.com
Many individuals with eczema notice that their skin becomes worse during the cold and dry winter months. This common skin condition affects millions of Americans and the number continues to grow each year. Characterized by inflamed, red plaques that can appear anywhere on the body, this condition causes skin to become dry, irritated and itchy. There is hope, however, for treating this condition. An article featured on YouBeauty.com focuses on products that provide relief for eczema symptoms. One of the top choices is FixMySkin Healing Body Balm with 1% Hydrocortisone invented by Dr. Joel Schlessinger and his son, Daniel.
Dr. Joel Schlessinger recommends this balm because it soothes irritating symptoms.
While there is no cure for eczema, there are ways to prevent your symptoms from becoming worse. Cold, dry climates often exacerbate symptoms so it is important to maintain moisturized skin during the winter months. You should also avoid skin care products that contain irritating ingredients such as fragrances. These additives can further irritate the complexion and leave skin dry and itchy.
When treating eczema, moisturization is often not enough to eliminate symptoms completely. Regularly applying lotion is important, but it is also necessary to apply a product with a topical steroid to actively heal the skin.
Dr. Joel Schlessinger and his son’s invention contains hydrocortisone to heal damaged skin.
Made with 1% hydrocortisone, FixMySkin Healing Body Balm relieves itching, flaking and irritation.
“It’s useful for a variety of conditions ranging from eczema to dry skin, poison ivy and even minor burns,” Dr. Joel Schlessinger says.
He recommends applying this product to irritated areas up to five times a day. You can use this balm on your hands, cuticles, elbows, knees and even the lips. The travel-friendly design allows you to take it with you anywhere.
Leave your questions or concerns for Dr. Joel Schlessinger in the comments section.